DK0539805T3 - Phthalaziner indeholdende en ethergruppe i 1-stilling og fremgangsmåde til fremstilling deraf - Google Patents

Phthalaziner indeholdende en ethergruppe i 1-stilling og fremgangsmåde til fremstilling deraf

Info

Publication number
DK0539805T3
DK0539805T3 DK92117672.3T DK92117672T DK0539805T3 DK 0539805 T3 DK0539805 T3 DK 0539805T3 DK 92117672 T DK92117672 T DK 92117672T DK 0539805 T3 DK0539805 T3 DK 0539805T3
Authority
DK
Denmark
Prior art keywords
radical
substituted
phenyl
alkyl
radicals
Prior art date
Application number
DK92117672.3T
Other languages
Danish (da)
English (en)
Inventor
Juergen Prof Engel
Bernhard Dr Kutscher
Gerhard Dr Scheffler
Ilona Dr Fleischhauer
Stefan Prof Szelenyi
Ulrich Dr Werner
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Application granted granted Critical
Publication of DK0539805T3 publication Critical patent/DK0539805T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK92117672.3T 1991-10-31 1992-10-16 Phthalaziner indeholdende en ethergruppe i 1-stilling og fremgangsmåde til fremstilling deraf DK0539805T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4135910 1991-10-31

Publications (1)

Publication Number Publication Date
DK0539805T3 true DK0539805T3 (da) 1998-03-23

Family

ID=6443832

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92117672.3T DK0539805T3 (da) 1991-10-31 1992-10-16 Phthalaziner indeholdende en ethergruppe i 1-stilling og fremgangsmåde til fremstilling deraf

Country Status (20)

Country Link
US (1) US5354750A (cg-RX-API-DMAC10.html)
EP (1) EP0539805B1 (cg-RX-API-DMAC10.html)
JP (1) JPH05222002A (cg-RX-API-DMAC10.html)
KR (1) KR930007914A (cg-RX-API-DMAC10.html)
CN (1) CN1071916A (cg-RX-API-DMAC10.html)
AT (1) ATE157656T1 (cg-RX-API-DMAC10.html)
AU (1) AU660726B2 (cg-RX-API-DMAC10.html)
BR (1) BR9204187A (cg-RX-API-DMAC10.html)
CA (1) CA2081819A1 (cg-RX-API-DMAC10.html)
DE (2) DE59208852D1 (cg-RX-API-DMAC10.html)
DK (1) DK0539805T3 (cg-RX-API-DMAC10.html)
ES (1) ES2108066T3 (cg-RX-API-DMAC10.html)
FI (1) FI924934A7 (cg-RX-API-DMAC10.html)
GR (1) GR3025141T3 (cg-RX-API-DMAC10.html)
HU (2) HUT62866A (cg-RX-API-DMAC10.html)
IL (1) IL103601A0 (cg-RX-API-DMAC10.html)
MX (1) MX9206245A (cg-RX-API-DMAC10.html)
NO (1) NO924166L (cg-RX-API-DMAC10.html)
TW (1) TW211563B (cg-RX-API-DMAC10.html)
ZA (1) ZA928420B (cg-RX-API-DMAC10.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9226573D0 (en) * 1992-12-21 1993-02-17 Ici Plc Heterocyclic compounds
US6635642B1 (en) 1997-09-03 2003-10-21 Guilford Pharmaceuticals Inc. PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same
US20020028813A1 (en) * 1997-09-03 2002-03-07 Paul F. Jackson Thioalkyl compounds, methods, and compositions for inhibiting parp activity
US6291425B1 (en) 1999-09-01 2001-09-18 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
US6197785B1 (en) 1997-09-03 2001-03-06 Guilford Pharmaceuticals Inc. Alkoxy-substituted compounds, methods, and compositions for inhibiting PARP activity
US6426415B1 (en) 1997-09-03 2002-07-30 Guilford Pharmaceuticals Inc. Alkoxy-substituted compounds, methods and compositions for inhibiting parp activity
US6514983B1 (en) 1997-09-03 2003-02-04 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
US6346536B1 (en) 1997-09-03 2002-02-12 Guilford Pharmaceuticals Inc. Poly(ADP-ribose) polymerase inhibitors and method for treating neural or cardiovascular tissue damage using the same
US6395749B1 (en) 1998-05-15 2002-05-28 Guilford Pharmaceuticals Inc. Carboxamide compounds, methods, and compositions for inhibiting PARP activity
US6387902B1 (en) 1998-12-31 2002-05-14 Guilford Pharmaceuticals, Inc. Phenazine compounds, methods and pharmaceutical compositions for inhibiting PARP
US6723733B2 (en) 2000-05-19 2004-04-20 Guilford Pharmaceuticals, Inc. Sulfonamide and carbamide derivatives of 6(5H)phenanthridinones and their uses
AU2002220241A1 (en) * 2000-12-01 2002-06-11 Iconix Pharmaceuticals, Inc. Parb inhibitors
GB0507298D0 (en) 2005-04-11 2005-05-18 Novartis Ag Organic compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2484029A (en) * 1945-12-21 1949-10-11 Ciba Pharm Prod Inc Hydrazine derivatives of pyridazine compounds
US3882119A (en) * 1970-01-27 1975-05-06 Lepetit Spa Tetracyclic substituted phthalazine compounds
IL48319A0 (en) * 1974-10-26 1975-12-31 Merck Patent Gmbh Araliphatic nitrogen compounds and a process for their preparation
JPH01261386A (ja) * 1988-04-11 1989-10-18 Nisshin Flour Milling Co Ltd 新規な2―ピリジルメチルチオ誘導体及びそれを含有する抗潰瘍剤

Also Published As

Publication number Publication date
AU2747192A (en) 1993-05-06
NO924166D0 (no) 1992-10-29
FI924934L (fi) 1993-05-01
FI924934A7 (fi) 1993-05-01
DE59208852D1 (de) 1997-10-09
HUT62866A (en) 1993-06-28
TW211563B (cg-RX-API-DMAC10.html) 1993-08-21
AU660726B2 (en) 1995-07-06
MX9206245A (es) 1993-05-01
US5354750A (en) 1994-10-11
GR3025141T3 (en) 1998-02-27
BR9204187A (pt) 1993-05-04
ZA928420B (en) 1993-05-14
DE4234933A1 (de) 1993-05-06
JPH05222002A (ja) 1993-08-31
NO924166L (no) 1993-05-03
HU9203431D0 (en) 1993-01-28
HU211863A9 (en) 1995-12-28
ES2108066T3 (es) 1997-12-16
EP0539805B1 (de) 1997-09-03
EP0539805A1 (de) 1993-05-05
KR930007914A (ko) 1993-05-20
CN1071916A (zh) 1993-05-12
FI924934A0 (fi) 1992-10-30
ATE157656T1 (de) 1997-09-15
CA2081819A1 (en) 1993-05-01
IL103601A0 (en) 1993-03-15

Similar Documents

Publication Publication Date Title
SE8503888D0 (sv) Heterocykliska derivat
ZA928420B (en) New phthalazines containing ether or thioether group in the 1-position and a process for their preparation.
MY107756A (en) Piperazine derivatives.
FI930970A0 (fi) Imidazolderivat med bifenylsulfonylurea- eller bifenylsulfonyluretansidokedja, foerfaranden foer framstaellning av dessa och anvaendning av dessa
TW235297B (cg-RX-API-DMAC10.html)
NO150719C (no) Trijoderte baser og roentgenkontrastmidler inneholdende salter av slike baser
DE3363581D1 (en) Pyridine-carboxylic-acid esters, process for their preparation and their use as pharmaceutical compositions
DE3376749T2 (cg-RX-API-DMAC10.html)
DE3368414D1 (en) 1,4-dihydropyridines, processes for their preparation and their use in medicines
HUT37797A (en) Process for production of tetrahydro-tieno-piridinderivatives and medical preparatives containing of such compounds
DK432086A (da) Fremgangsmaade til fremstilling af beta-lactamforbindelser eller saltederaf
AU588656B2 (en) New fluorine-containing 1,4-dihydropyridines, process for their preparation and their use as medicaments
NO873564L (no) Nye tyroninderivater.
FI971177A0 (fi) Bisyklisiä karboksiamideja 5-HT1A-antagonisteina
ES8103740A1 (es) Procedimiento para la obtencion de nuevos derivados de la piperacina metanimina